The critique of electroconvulsive therapy and psychiatric drug use defines the career of Peter Breggin, an American psychiatrist who has spent decades challenging established biological models in medicine. Born in 1936, he emerged as a vocal opponent of pharmaceutical intervention, advocating instead for psychotherapy, education, and empathy to address human suffering rather than relying on chemical or physical brain-disabling treatments.
Academic Foundation and Early Training
Breggin graduated from George W. Hewlett High School in 1954 and Harvard College in 1958. His medical training continued at Case Western Reserve University. He completed a mixed internship at the State University of New York Upstate Medical University in Syracuse, followed by psychiatric residency training at Harvard's Massachusetts Mental Health Center and additional years at SUNY. During this period, he also served as a teaching fellow at Harvard Medical School.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Professional Appointments and Advocacy
After his training, Breggin completed a two-year staff appointment at the National Institute of Mental Health, where he focused on the development of mental health centers. He held faculty positions at the Washington School of Psychiatry, the Johns Hopkins University Department of Counseling, and the George Mason University Institute for Conflict Analysis and Resolution. In 1972, he founded the Center for the Study of Psychiatry, which later transitioned through several names, including the International Society for Ethical Psychology and Psychiatry.
Critique of Biological Psychiatry
Breggin is known for challenging the efficacy of psychiatric medication and electroconvulsive therapy. His written works, including Toxic Psychiatry, Talking Back to Prozac, Talking Back to Ritalin, and Brain-Disabling Treatments in Psychiatry, argue that drug-based interventions often cause harm, such as the neurological damage associated with neuroleptics. He advocates for psychosocial approaches, suggesting that pharmaceutical industry interests frequently bias medical research and clinical guidelines.
Public Engagement and Later Work
Throughout his career, Breggin has testified before U.S. Congress and federal agencies, including acting as an expert for the Federal Aviation Agency regarding psychiatric drug side effects. He maintained a private practice for over 35 years in Washington, D.C., and Bethesda, Maryland, before moving to Ithaca, New York, in 2002. He continues his work alongside his wife, Ginger, focusing on ethical psychology and challenging contemporary biological psychiatry.
Fast facts
- Born: 1936
- Nationality: United States
- Education: Harvard University, Case Western Reserve University
- Private practice start: 1968
- Documentary: The Conscience of Psychiatry (2009)
- Primary focus: Clinical psychopharmacology
- Notable book: Toxic Psychiatry
Questions readers ask
What is Breggin's view on psychiatric drugs?
He argues that psychiatric drugs are inherently dangerous and that their negative side effects often outweigh potential benefits, advocating for their replacement with psychotherapy.
Where does Peter Breggin practice today?
He currently lives in the Finger Lakes region and practices psychiatry in Ithaca, New York.
Achievements
- Held posts at National Institute of Mental Health and Johns Hopkins University
- Fields: psychiatry
.jpg)